Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lung neoplasm
ADR ID BADD_A06047
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.04      Respiratory tract and pleural neoplasms malignancy unspecified NEC
16.19.04.001      Lung neoplasm
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.006      Lung neoplasm
Description Tumors or cancer of the LUNG. [MeSH]
MedDRA Code 10062042
MeSH ID D008175
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lung neoplasm NOS | Lung neoplasm | Lung Neoplasms | Pulmonary Neoplasms | Neoplasms, Lung | Lung Neoplasm | Neoplasm, Lung | Neoplasms, Pulmonary | Neoplasm, Pulmonary | Pulmonary Neoplasm | Lung Cancer | Cancer, Lung | Cancers, Lung | Lung Cancers | Pulmonary Cancer | Cancer, Pulmonary | Cancers, Pulmonary | Pulmonary Cancers | Cancer of the Lung | Cancer of Lung
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02058Sorafenib0.000112%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.000279%
BADD_D02443Tiotropium0.000057%
BADD_D02480Alectinib0.000112%
The 2th Page    First    Pre   2    Total 2 Pages